In summary, a high discordance of EGFR mutations were identified between tumors in patients with SMPLA, so the detection of EGFR mutation may be used routinely to prevents unnecessary adjuvant treatment for patients with histologically similar synchronous primary lung cancers. The gene discussed is EGFR; the disease is lung cancer.